By not prioritizing the use of pharmacy benefit management drug rebates, the administration is hurting companies, who shoulder the burden of rising costs by all stakeholders in the supply chain.
Many pharmacy benefit managers promote discounts and drug rebates that may look good on paper, but often provide no transparency of true costs. This can result in employers paying much more than they should.
By tying its clinical database to physicians’ EHR systems, the drug chain hopes to avoid patient sticker shock and prescription abandonment at the point of sale.
Aetna will pass on the discounts it negotiates on prescription drugs to about 3 million of its members, in the latest move to address complaints about the cost of medicine.
